Nachrichten zur Teva Pharmaceutical Industries Limited Aktie

UPDATE 1-Teva to pay $225 mln to settle price-fixing charges

...(Adds details in paragraph 2-4) Aug 21 (Reuters) - Teva......…

Teva, Glenmark to Pay $275 Million to DOJ for Drug Price-Fixing

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceuticals agrees to pay $225 million fine to settle price-fixing charges

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. TEVA, said Monday that it has reached an agreement with…

Teva Pharmaceuticals to pay $225 million to settle price-fixing charges

...(Reuters) - Teva Pharmaceuticals will pay a fine of $225 million......…

Teva Pharmaceuticals to pay $225 mln to settle price-fixing charges

...Aug 21 (Reuters) - Teva Pharmaceuticals will pay a fine of $225......…

Teva to pay $225 million in fines and divest generic drug to resolve price-fixing charges

Its the latest resolution in a string of cases related to price-fixing, referring to competitors banding together to artificially set…

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide…

Teva agrees to pay $126 million to US hospitals over opioids

...By Brendan Pierson (Reuters) - Teva Pharmaceutical Industries Ltd......…

Teva agrees to pay $126 mln to US hospitals over opioids

...By Brendan Pierson Aug 3 (Reuters) - Teva Pharmaceutical Industries......…

Insiderhandel: See "Remarks" verkauft Aktien von Teva Pharma Industries im Wert von 437.690$

Hughes, Eric A. - Vorstand - Tag der Transaktion: 2023-08-01...…

UPDATE 1-Teva CEO says not too late to launch Humira biosimilar in 2024

... (Reuters) - Teva Pharmaceutical Industries will still pursue launching...," Francis told Reuters after Teva issued second-quarter results. "Its always......…

Teva CEO sees no value now in separating brands, generics businesses

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharm CEO: Not too late to launch Humira biosimilar in 2024

...JERUSALEM (Reuters) - Teva Pharmaceutical Industries will still... this year. But I still see it as…

Teva Pharmaceutical Industries (TEVA) Q2 2023 Earnings Call Transcript

TEVA earnings call for the period ending June 30, 2023....…

Teva Pharmaceutical Shares Jump on Outlook Raise, 2Q Results

Teva Pharmaceutical Shares Jump on Outlook Raise, 2Q Results...…

Teva estimates $200M impact from DOJ price fixing case

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

6 stocks to watch on Wednesday: AMD, CVS, Teva, PayPal and more

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva returns to revenue growth, raises guidance

The Israeli pharmaceutical company beat the analysts expectations in the second quarter of 2023 with revenue of $3.9 billion and…

ROUNDUP: Teva Pharma Boosts FY23 Revenue Outlook

PETAH TIKVA (dpa-AFX) - While reporting financial results for the second quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) reaffirmed…

Teva Pharmaceutical Industries Limited Q2 Earnings Summary

PETAH TIKVA (dpa-AFX) - Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):Earnings: -$863 million in Q2 vs.…

Teva Pharmaceutical hoping for Q2 recovery after Q1 EPS disappointment.

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Exelixis, Teva settle patent dispute over cancer drug Cabometyx

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceuticals and Alvotech expand biosimilars partnership

Teva Pharmaceuticals Industries Ltd. TEVA and Alvotech ALVO announced Monday that they are expanding their collaboration in the U.S. biosimilars…

Teva, Alvotech Announce Expanded Strategic Partnership For Biosimilars

PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) announced on Monday that it has agreed with Alvotech (ALVO) to…

Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic…

Meilenstein für die Medizin von Morgen: Teva investiert in hochmoderne Biotech-Anlage

Drees & Sommer SE: Ulm (ots) - Es ist ein Projekt der Superlative: Die Ratiopharm-Mutter Teva investiert am Standort Ulm…

TEVA Pharmaceutical: Upgrade

Zürich (www.aktiencheck.de) - Rating-Update: Ashwani Verma, Analyst der UBS, stuft die Aktie des Biotechkonzerns TEVA Pharmaceutical Industries Ltd. (ISIN: US8816242098,…

Teva mulls $2b sale of API activities - report

The Israeli pharmaceutical company is working with advisors to gauge interest on such a sale, "Bloomberg" reports....…

Teva considering $2B sale of active pharmaceutical ingredients unit -report

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva (TEVA) Explores Sale of $2 Billion Active Ingredients Unit

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva seeks to reinvent itself as branded drug developer

After years of shrinking revenue, new CEO Richard Francis is switching the emphasis to innovation. "Globes" looks at Tevas drug…

Gilead, Teva acquitted in pay for delay generic HIV drugs case

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Deckers (DECK) to Benefit From Brand Strength Amid Headwinds

Deckers Outdoor (DECK) is well poised to benefit from strength across its HOKA and Teva brands, store expansion initiatives and…

Form 8-K TEVA PHARMACEUTICAL INDU For: Jun 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva settles price-fixing claims with State of Kentucky for $1.41M (update)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceuticals Reaches Deal With Kentucky AG To Settle Price-fixing Claims

PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, the U.S. subsidiary of Teva Pharmaceutical Industries Ltd. (TEVA), Monday said it has reached…

Teva settles price-fixing claims with State of Kentucky for $1.41B

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO),…

Why did Teva fall 20% in April-May?

An SEC filing reveals that major US-based shareholder Capital Research Global Investors sold its entire holding....…

Teva Pharmaceutical settles $193M opioid suit with the state of ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pharmaceutical Giants Set $19 Billion Opioid Settlement as States Debate How to Spend It

Teva, Allergan, CVS and Walgreens said enough states agreed to final agreements, adding to the billions flowing to communities....…

Teva, Walgreens, CVS, AbbVie to pay $17.3B in national opioid settlement

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

NY AG approves $17.3 billion opioid settlement with CVS, Walgreens, Teva and AbbVie’s Allergan

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRIEF-Attorney General James Announces Final National Settlement Agreements For $17.3 Bln With Teva, CVS And Walgreens - Statement

...June 9 (Reuters) - * ATTORNEY GENERAL JAMES ANNOUNCES FINAL NATIONAL......…

dpa-AFX ProFeed